Telethon has renewed the agreement with Rare Partners for the development of diagnostic tools and therapeutic approaches based on the results of research projects funded by the Telethon Foundation. Under this agreement, Rare Partners, a non-profit organization founded in 2010 in Milan and dedicated to the development of new solutions in the field of rare diseases, will continue to provide the Telethon Foundation with its skills and its network of experts for activities involving analysis and evaluation of possible applications in therapeutic and diagnostic fields.
In particular, Rare Partners will provide Telethon, with specific support to define a plan for the protection of intellectual property, clinical development and management of contacts with potential industrial partners, to universities and research centers funded by Telethon.Rare Partners Rare Partners Srl, founded in Milan in March 2010 and registered as a Social Enterprise, brings in the field of rare diseases a new approach in order to find diagnostic and therapeutic solutions, thanks to the creation of a network of collaborations with research institutes, charities and service organizations Rare Partners works as a virtual company that combines the use of non-profit financial resources (public and private) with its expertise in the industrial field, in order to create new opportunities for collaborations between the world of not profit organizations, the scientific community and biopharmaceutical companies.For more information: www.rarepartners.org.
